# A Prospective Cohort Study on Primary Cutaneous Amyloidosis

> **NCT06998875** · PHASE4 · RECRUITING · sponsor: **Army Medical University, China** · enrollment: 56 (estimated)

## Conditions studied

- Primary Cutaneous Amyloidosis

## Interventions

- **DRUG:** Tofacitinib and Acitretin Capsules.
- **DRUG:** Acitretin Capsules.

## Key facts

- **NCT ID:** NCT06998875
- **Lead sponsor:** Army Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2025-10
- **Final completion:** 2025-12
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06998875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06998875, "A Prospective Cohort Study on Primary Cutaneous Amyloidosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06998875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*